What is TCMD's current stock price?

TCMD (Tactile Systems Technology, Inc.) is currently trading at $24.90 with a market cap of $561.7M.

What sector is Tactile Systems Technology, Inc. in?

Tactile Systems Technology, Inc. (TCMD) operates in the Healthcare sector, specifically in the Medical - Devices industry.

Is TCMD a good stock to buy?

Analysts have a Buy consensus on TCMD with a price target of $39.25. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

TCMD Tactile Systems Technology, Inc.

Healthcare

$24.90-2.85%ClosedMarket Cap: $561.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

28.67

PEG

2.29

P/B

2.58

P/S

1.64

EV/EBITDA

12.29

DCF Value

$62.33

FCF Yield

7.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

75.7%

Operating Margin

9.4%

Net Margin

5.9%

ROE

9.7%

ROA

7.5%

ROIC

7.9%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$75.3M	$-1.8M	$—
Q4 null	$103.6M	$10.6M	$—
FY null	$329.5M	$19.1M	$—
Q3 null	$85.8M	$8.2M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$39.25

Target (Median)

$40.00

Target Range

$35.00 - $42.00

1 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell

BTIGBuy

2026-05-21

B. Riley SecuritiesBuy

2026-05-07

B. Riley SecuritiesNeutral

2026-02-18

Piper SandlerOverweight

2026-02-18

BTIGBuy

2026-02-18

Trading Activity

Insider Trades

View All

Birkemeyer Elaine M.officer: CHIEF FINANCIAL OFFICER

SellWed May 13

Washington Boyd Vindelldirector

SellFri May 08

Volkart Carmen Bdirector

SellFri May 08

Shafer David Brentdirector

SellFri May 08

Pearson Andreadirector

SellFri May 08

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

Exchange

—

Beta

0.82

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Peers